P15941 (MUC1_HUMAN) Homo sapiens (Human)
Mucin-1 UniProtKBInterProSTRINGInteractive Modelling
1255 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5; Isoform 6; Isoform 7; Isoform 8; Isoform 9; Isoform 10; Isoform 11; Isoform 12; Isoform 13; Isoform 14; Isoform 15; Isoform 16; Isoform 17)
It is possible new templates exist for this target since these models were created.
Available Structures
18 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Crystal structure of Antibody 16A in complex with MUC1 Glycopeptide(GlycoST) |
Heteromer | 2×NGA; | ||||
Assess | ||||||
Crystal structure of SN-101 mAb in complex with MUC1 glycopeptide |
Heteromer | 1×A2G; | ||||
Assess | ||||||
Crystal structure of antibody 14A in complex with MUC1 glycopeptide(GlycoS) |
Heteromer | 1×NGA; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF THE TUMOR SPECIFIC ANTIBODY SM3 COMPLEX WITH ITS PEPTIDE EPITOPE |
Heteromer P01723; P01801; | 8×CD; 2×CL; | ||||
Assess | ||||||
Crystal structure of antibody 14A in complex with MUC1 glycopeptide(GlycoST) |
Heteromer | 2×NGA; | ||||
Assess | ||||||
Crystal structure of Antibody 16A in complex with MUC1 Glycopeptide(GlycoT) |
Heteromer | 1×NGA; | ||||
Assess | ||||||
Enhanced MHC class I binding and immune responses through anchor modification of the non-canonical … |
Heteromer P01887; Q3UBW0; | 1×NAG; 1×NAG; 2×PO4; 4×MPD; | ||||
Assess | ||||||
Crystal structure of antibody 14A in complex with MUC1 Glycopeptide(GlycoT) |
Heteromer | 1×NGA; | ||||
Assess | ||||||
Crystal structure of Antibody 16A in complex with MUC1 peptide |
Heteromer | |||||
Assess | ||||||
Crystal structure of therapeutic mAB AR20.5 in complex with MUC1 peptide |
Heteromer | 1×NGA; | ||||
Assess | ||||||
Crystal structure of scFv-SM3 in complex with compound 3 |
Heteromer | 10×EDO; 1×EEN; | ||||
Assess | ||||||
Crystal structure of scFv-SM3 in complex with compound 2 |
Heteromer | 8×EDO; 1×EEQ; | ||||
Assess | ||||||
Crystal structure of therapeutic mAB AR20.5 in complex with MUC1 peptide |
Heteromer | |||||
Assess | ||||||
scFv-1SM3 in complex with glycopeptide containing an sp2-imino sugar |
Heteromer | 4×EDO; 1×N8W; | ||||
Assess | ||||||
Crystal structure of DmC1GalT1 in complex with UDP-Mn2+ and the APD-TGalNAc-RP |
Heteromer Q7K237; | 2×UDP; 3×EDO; 2×MN; 2×A2G; | ||||
Assess | ||||||
Crystal structure of the Mucin-1 SEA domain, L1105M mutant, Selenium-derivative | homo-2-mer | |||||
Assess | ||||||
Crystal structure of the Mucin-1 SEA domain | homo-2-mer | |||||
Assess | ||||||
Solution structure of the SEA domain of human mucin 1 (MUC1) | homo-2-mer | |||||
Assess |
1 SWISS-MODEL model
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
7dwx.1.B | monomer | 0.53 | 18.45 | |||
Assess |
15 SWISS-MODEL models built on isoform sequence
Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
---|---|---|---|---|---|---|
Isoform 2 | 7dwx.1.B | monomer | 0.53 | 18.45 | ||
Assess | ||||||
Isoform 3 | 6dmo.1.A | monomer | 0.64 | 25.00 | ||
Assess | ||||||
Isoform 3 | 7dwx.1.B | monomer | 0.54 | 18.45 | ||
Assess | ||||||
Isoform 4 | 7v61.1.F | monomer | 0.55 | 18.45 | ||
Assess | ||||||
Isoform 5 | 2acm.1.A | monomer | 0.51 | 87.80 | ||
Assess | ||||||
Isoform 6 | 7y75.1.B | monomer | 0.55 | 17.92 | ||
Assess | ||||||
Isoform 7 | 7nat.1.V | monomer | 0.51 | 23.61 | ||
Assess | ||||||
Isoform 8 | 2acm.1.A | monomer | 0.74 | 100.00 | ||
Assess | ||||||
Isoform 10 | 7y75.1.B | monomer | 0.60 | 22.22 | ||
Assess | ||||||
Isoform 11 | 7nat.1.V | monomer | 0.50 | 23.61 | ||
Assess | ||||||
Isoform 12 | 2acm.1.A | monomer | 0.52 | 69.70 | ||
Assess | ||||||
Isoform 13 | 2acm.1.A | monomer | 0.62 | 100.00 | ||
Assess | ||||||
Isoform 13 | 6bsc.1.B | monomer | 0.60 | 95.56 | ||
Assess | ||||||
Isoform 15 | 6bsc.1.B | monomer | 0.77 | 100.00 | ||
Assess | ||||||
Isoform 17 | 7nat.1.V | monomer | 0.51 | 23.61 | ||
Assess |